brelovitug
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
3
Phase 4
0
Earliest trial started Mar 25, 2025 (NCT06907290)
Timeline
Indications
Studied for
Mechanism of action
- hepatitis d virusINHIBITOR
hepatitis d virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07298330 | Phase 3 | Dec 31, 2025 | Bluejay Therapeutics, Inc. |
| NCT07200908 | Phase 3 | Aug 27, 2025 | Bluejay Therapeutics, Inc. |
| NCT06907290 | Phase 2/Phase 3 (Phase 3) | Mar 25, 2025 | Bluejay Therapeutics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bluejay Therapeutics, Inc. | For profit | 3 | 3 | 1 | 2025 |
1 organizations
Page 1 / 1